mistletoe extract + PS76A2

mistletoe extract + PS76A2 is a combination drug containing mistletoe extract, a herbal preparation derived from the plant *Viscum album*, and PS76A2, for which no definitive information could be found in available databases and literature as of 2025. Mistletoe extract is widely researched for potential immunomodulatory, antineoplastic, and adjunctive cancer therapies. Its mechanism of action is believed to involve modulation of the immune system, apoptosis induction, and inhibition of cell proliferation. The second component, PS76A2, appears to be a code name or investigational agent but its nature—whether small molecule, biologic, or peptide—is undetermined from accessible sources. Combination therapies including mistletoe extract are typically explored for oncology-related indications, but specific data on this exact combination is lacking.

Other names

mistletoe extractPS76A2PS-76A2PS 76A2